Skip to content

KMTS KMTS Additional Paid-In Capital

Additional Paid-In Capital at other companies

Medtronic logo
MedtronicMDT
$20.93B+0.4%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$1B+11.4%
Haemonetics logo
HaemoneticsHAE
$554.14M+5.9%
ICU Medical logo
ICU MedicalICUI
$1.47B+3.5%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$6.73B+2.1%
Baxter International logo
Baxter InternationalBAX
$6.21B-1.5%

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.32B+70.8%
Enterprise value$1.07B
P/S15.7×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's additional paid-in capital?
KMTS (KMTS) reported additional paid-in capital of $842.67M in Q4 2025.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.